Catarina Pinto1, Maria João Malaquias2, Helena Pessegueiro Miranda3, Teresa Temudo4, Ermelinda Silva5, Cristina Ramos1, Marina Magalhães2. 1. Neuroradiology Department Centro Hospitalar Universitário do Porto Porto Portugal. 2. Neurology Department Centro Hospitalar Universitário do Porto Porto Portugal. 3. Hepatic Pancreatic Transplantation Unit Centro Hospitalar Universitário do Porto Porto Portugal. 4. Neuropediatric Unit, Centro Materno-Infantil do Norte Centro Hospitalar Universitário do Porto Porto Portugal. 5. Pediatric Gastroenterology Unit, Centro Materno-Infantil do Norte Centro Hospitalar Universitário do Porto Porto Portugal.
Abstract
Background: Neurological Wilson's disease (WD) presentation in the pediatric population is rare, and liver transplantation (LT) in these patients remains controversial. The aim of the present study was to assess the role of brain magnetic resonance imaging (MRI) in predicting reversion of brain lesions and neurological outcomes in pediatric WD patients after LT. Methods: Patients with confirmed WD (Leipzig score ≥4), disease onset in pediatric age (<18 years), neurological involvement, and submitted to LT were selected. Clinical records and pre- and post-LT brain MRI were evaluated. Results: Six patients met the pre-defined inclusion criteria, one of whom died shortly after LT and was excluded. The indication for LT was end-stage liver disease in two patients and neurological worsening despite optimized treatment in three patients. After LT, the neurological picture progressively improved in all patients. Pre-LT brain MRI showed T1-weighted hyperintensities in four patients, which quickly resolved afterward. T2-weighted hyperintensities were observed in four patients before LT, completely resolving in one patient, stabilizing in two, and improving in one after LT. A direct correlation could not be found between clinical and neuroradiological improvement. Progressive clinical improvement was observed even in patients with irreversible brain MRI changes. Conversely, some patients with normal MRI had only slight neurological improvement. Conclusions: The pattern of T2-weighted hyperintensities after LT was unpredictable and did not correlate with neurological outcomes, suggesting that these changes may not entail irreversible clinical damage. Therefore, brain MRI does not seem to have prognostic value for assessing clinical response to LT.
Background: Neurological Wilson's disease (WD) presentation in the pediatric population is rare, and liver transplantation (LT) in these patients remains controversial. The aim of the present study was to assess the role of brain magnetic resonance imaging (MRI) in predicting reversion of brain lesions and neurological outcomes in pediatric WD patients after LT. Methods: Patients with confirmed WD (Leipzig score ≥4), disease onset in pediatric age (<18 years), neurological involvement, and submitted to LT were selected. Clinical records and pre- and post-LT brain MRI were evaluated. Results: Six patients met the pre-defined inclusion criteria, one of whom died shortly after LT and was excluded. The indication for LT was end-stage liver disease in two patients and neurological worsening despite optimized treatment in three patients. After LT, the neurological picture progressively improved in all patients. Pre-LT brain MRI showed T1-weighted hyperintensities in four patients, which quickly resolved afterward. T2-weighted hyperintensities were observed in four patients before LT, completely resolving in one patient, stabilizing in two, and improving in one after LT. A direct correlation could not be found between clinical and neuroradiological improvement. Progressive clinical improvement was observed even in patients with irreversible brain MRI changes. Conversely, some patients with normal MRI had only slight neurological improvement. Conclusions: The pattern of T2-weighted hyperintensities after LT was unpredictable and did not correlate with neurological outcomes, suggesting that these changes may not entail irreversible clinical damage. Therefore, brain MRI does not seem to have prognostic value for assessing clinical response to LT.
Authors: Robert P Sutcliffe; Donal D Maguire; Paolo Muiesan; Anil Dhawan; Giorgina Mieli-Vergani; John G O'Grady; Mohammed Rela; Nigel D Heaton Journal: Transplantation Date: 2003-04-15 Impact factor: 4.939
Authors: Ayşe Kaçar Bayram; Hakan Gümüş; Duran Arslan; Güldemet Kaya Özçora; Sefer Kumandaş; Neslihan Karacabey; Mehmet Canpolat; Hüseyin Per Journal: Turk Pediatri Ars Date: 2016-03-01
Authors: G Schumacher; K P Platz; A R Mueller; R Neuhaus; T Steinmüller; W O Bechstein; M Becker; W Luck; M Schuelke; P Neuhaus Journal: Clin Transplant Date: 1997-06 Impact factor: 2.863
Authors: S Sevmis; H Karakayali; I Aliosmanoglu; U Yilmaz; F Ozcay; A Torgay; G Arslan; M Haberal Journal: Transplant Proc Date: 2008 Jan-Feb Impact factor: 1.066